{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4270"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4270","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"Study of modified Salinomycin analogs on inhibition of triple negative breast cancer metastasis and invasion","abstract":"Triple negative breast cancer (TNBC) is a more aggressive type of breast cancer which contains faster growth, higher metastasis rate and worse prognosis. The main challenge toward treatment of this type of cancer is being heterogeneous. Recently, Salinomycin (SAL) has been considered as a potential agent for triple negative breast cancer treatment. However, chemical modification of SAL is needed to improve SAL selectivity to cations and decrease its cytotoxicity. The purpose of this study was to evaluate the effect of chemically modified analogs of SAL on the viability, metastasis, Wnt pathway as well as angiogenesis of Triple negative breast cancer (TNBC) cell lines using MTT assay, Western blot and Invasion assay. Obtained results indicated that the tested compounds may have the potential to inhibit angiogenesis, metastasis and alter Wnt signaling pathway. However, more studies are needed to clarify their effects on CSCs, in vivo and moreover, the effects on both tumor and normal cells.","abstract_html":"Triple negative breast cancer (TNBC) is a more aggressive type of breast cancer which contains faster growth, higher metastasis rate and worse prognosis. The main challenge toward treatment of this type of cancer is being heterogeneous. Recently, Salinomycin (SAL) has been considered as a potential agent for triple negative breast cancer treatment. However, chemical modification of SAL is needed to improve SAL selectivity to cations and decrease its cytotoxicity. The purpose of this study was to evaluate the effect of chemically modified analogs of SAL on the viability, metastasis, Wnt pathway as well as angiogenesis of Triple negative breast cancer (TNBC) cell lines using MTT assay, Western blot and Invasion assay. Obtained results indicated that the tested compounds may have the potential to inhibit angiogenesis, metastasis and alter Wnt signaling pathway. However, more studies are needed to clarify their effects on CSCs, in vivo and moreover, the effects on both tumor and normal cells.","abstract_has_math":false,"creators":["Malekmarzban, Farnaz"],"institution":null,"degree_name":"Master of Science (M.S.) in Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Subash Jonnalagadda, Ph.D.","Manoj Pandey, Ph.D.","Kandalam Ramanujachary, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:46Z","subjects":["triple negative breast cancer","Salinomycin","Cancer--Treatment","Chemistry","Medicinal-Pharmaceutical Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3264","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3264","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4270","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Subash Jonnalagadda, Ph.D.","Manoj Pandey, Ph.D.","Kandalam Ramanujachary, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Malekmarzban, Farnaz"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-07-01T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-06-28T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.) in Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["triple negative breast cancer","Salinomycin","Cancer--Treatment","Chemistry","Medicinal-Pharmaceutical Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3264"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Triple negative breast cancer (TNBC) is a more aggressive type of breast cancer which contains faster growth, higher metastasis rate and worse prognosis. The main challenge toward treatment of this type of cancer is being heterogeneous. Recently, Salinomycin (SAL) has been considered as a potential agent for triple negative breast cancer treatment. However, chemical modification of SAL is needed to improve SAL selectivity to cations and decrease its cytotoxicity. The purpose of this study was to evaluate the effect of chemically modified analogs of SAL on the viability, metastasis, Wnt pathway as well as angiogenesis of Triple negative breast cancer (TNBC) cell lines using MTT assay, Western blot and Invasion assay. Obtained results indicated that the tested compounds may have the potential to inhibit angiogenesis, metastasis and alter Wnt signaling pathway. However, more studies are needed to clarify their effects on CSCs, in vivo and moreover, the effects on both tumor and normal cells."]},{"key":"dc:title","label":"Title","values":["Study of modified Salinomycin analogs on inhibition of triple negative breast cancer metastasis and invasion"]}]}],"canonical_facts":{"dc:contributor":["Subash Jonnalagadda, Ph.D.","Manoj Pandey, Ph.D.","Kandalam Ramanujachary, Ph.D."],"dc:creator":["Malekmarzban, Farnaz"],"dc:date.available":["2024-07-01T07:00:00Z"],"dc:date.created":["2024-06-28T07:00:00Z"],"dc:description.abstract":["Triple negative breast cancer (TNBC) is a more aggressive type of breast cancer which contains faster growth, higher metastasis rate and worse prognosis. The main challenge toward treatment of this type of cancer is being heterogeneous. Recently, Salinomycin (SAL) has been considered as a potential agent for triple negative breast cancer treatment. However, chemical modification of SAL is needed to improve SAL selectivity to cations and decrease its cytotoxicity. The purpose of this study was to evaluate the effect of chemically modified analogs of SAL on the viability, metastasis, Wnt pathway as well as angiogenesis of Triple negative breast cancer (TNBC) cell lines using MTT assay, Western blot and Invasion assay. Obtained results indicated that the tested compounds may have the potential to inhibit angiogenesis, metastasis and alter Wnt signaling pathway. However, more studies are needed to clarify their effects on CSCs, in vivo and moreover, the effects on both tumor and normal cells."],"dc:identifier":["https://rdw.rowan.edu/etd/3264"],"dc:subject":["triple negative breast cancer","Salinomycin","Cancer--Treatment","Chemistry","Medicinal-Pharmaceutical Chemistry"],"dc:title":["Study of modified Salinomycin analogs on inhibition of triple negative breast cancer metastasis and invasion"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (M.S.) in Pharmaceutical Sciences"]},"updated_at":"2026-11-19T08:59:46Z"}